Alta Partners

Alta Partners is a venture capital firm investing in the healthcare and life sciences sector.

Business Model:

Revenue: $5M

Employees: 11-50

Rankings

Detailed Alta Partners Information

Geographic Data

Alta Partners headquarters map

Address: 1 Embarcadero Ctr

City: San Francisco

State: CA

Zip: 94111

Country: US

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$405M

Metrics

5,209,985Website Global Rank

1,756Website Monthly Traffic

Twitter Followers

Description

Alta Partners is a venture capital firm investing in the healthcare and life sciences sector. Their diverse and integrated team brings together a powerful depth of knowledge and experience, delivering tangible results for their companies and their investors.

Contact Phone:
+14153624022

Contact Email:

Announced Date Company Transaction Money Raised
1/2009 7TM Pharma Venture Round 0
1/2008 Calistoga Pharmaceuticals Series A 5.2M
2/2021 PatientsLikeMe Venture Round 0
3/2009 Sutro Biopharma Series B 15M
12/2007 Sutro Biopharma Series B 21M
4/2004 Tacit Knowledge Series A 7M
8/2007 Nereus Pharmaceuticals Series D 0
10/2003 Arrow Therapeutics Series B 34.9M
3/2005 TorreyPines Therapeutics Series C 0
10/2005 Nereus Pharmaceuticals Series D 0
4/2004 Ablynx Series B 30M
5/2004 Plexxikon Series B 0
4/2009 Aerovance Venture Round 38M
5/2008 Esperion Series A 22.8M
5/2009 Calistoga Pharmaceuticals Series B 30M
6/2003 Intarcia Therapeutics Series D 43M
12/2001 USGI Medical Series A 3.5M
5/2001 AGY Series B 13M
7/2011 SARcode Bioscience Series B 44M
1/2007 SARcode Bioscience Series A 25M
2/2011 VertiFlex Venture Round 14M
8/2005 Alba Therapeutics Series A 30M
8/2006 ChemoCentryx Series C 0
8/2007 Sierra Surgical Series A 7.1M
7/2008 Sierra Surgical Series B 14.5M
5/2012 Sutro Biopharma Series C 16.5M
5/2007 Prolacta Bioscience Series C 0
1/2011 PneumRx Venture Round 0
12/2013 Sutro Biopharma Series D 0
7/2018 Sutro Biopharma Series E 0
6/2007 7TM Pharma Series D 22M
11/2012 Kiadis Pharma Venture Round 0
3/2006 7TM Pharma Series C 0
10/2008 ChemoCentryx Series E 50M
1/2004 TransMedics Series B 27.6M
5/2007 nCircle Network Security Venture Round 5M
8/2001 nCircle Network Security Series B 0
11/2019 EGenesis Series B 0
7/2013 aTyr Pharma Series D 49M
2/2002 Syntonix Pharmaceuticals Series B 35.8M
6/2007 Paracor Medical Series D 44M
4/2002 Dynavax Technologies Series D 0
10/2003 Anesiva Series D 20M
3/2009 Aegis Semiconductor Series E 3M
6/2000 NeurogesX Series A 8.4M
12/2001 R2 Technology Venture Round 0
3/2017 EGenesis Series A 0
3/2007 PneumRx Series B 0
6/2021 ImmuneID Series A 0
11/2009 CymaBay Therapeutics Series E 0
1/2017 Vir Biotechnology Venture Round 150M
2/2000 Reef Point Systems Venture Round 22M
3/2008 SurgRx Series G 19.8M
11/2006 Intradigm Corporation Series A 16M
12/2005 NeurogesX Series D 20M
2/2006 iSOCO Venture Round 357k
7/2008 MacroGenics Series D 12.5M
4/2000 Nereus Pharmaceuticals Series A 8.6M
3/2006 TransMedics Series C 0
11/2001 Biovitrum Venture Round -
3/2002 Agensys Series C 0
7/2003 PamGene Series B 11.3M
12/2002 Arrow Therapeutics Venture Round 10.9M
4/2010 Achaogen Series C 56M
5/2019 DispatchHealth Series B 33M
11/2006 Abionyx Pharma Series B 53.5M
10/2008 MacroGenics Series D 25M
11/2022 BetterVet Series A 40M
9/2002 Nanomix Series B 9M
3/2007 ChemoCentryx Series D 29.8M
2/2006 Netli Venture Round 18M
7/2002 Synad Technologies Series B 20.7M
4/2007 SurgRx Series F 20M
8/2000 ePhones Series C 10.5M
11/2003 Sanarus Medical Series C 19.1M
3/2005 Nanomix Series C 16M
3/2004 nCircle Network Security Venture Round 15M
7/2001 Tacit Software Series C 10M
10/2008 MAKO Surgical Post-IPO Equity 60M
11/2010 Sutro Biopharma Series C 36.5M
2/2014 Neothetics Series C 8M
12/2012 Neothetics Series C 20.6M
8/2010 Taligen Therapeutics Series B 10M
5/2004 Aegis Semiconductor Series C 10M
10/2013 Immune Design Series C 49M
4/2000 Definity Health Venture Round 23M
7/2010 Cara Therapeutics Series D 0
1/2002 Renovis Series B 0
10/2020 Be Biopharma Series A 52M
1/2002 Coapt Systems Series B 6.3M
6/2010 Nereus Pharmaceuticals Series E 0
4/2007 aTyr Pharma Series B 10.5M
10/2018 CuraSen Therapeutics Series A 54.5M
3/2002 Aegis Semiconductor Series B 16M
1/2020 Tyra Biosciences Series A 50M
7/2022 Everside Health Venture Round 0
2/2007 Chimerix Series D 23.1M
8/2008 Xelerated Series E 0
5/2007 Xelerated Series D 0
10/2012 ZS Pharma Series C 0
12/2017 Allakos Series B 100M
3/2007 Aerovance Series C 60M
5/2013 Lumena Pharmaceuticals Series A 23M
8/2009 Chimerix Series E 16.1M
1/2008 Taligen Therapeutics Series B 65M
4/2009 Sunesis Pharmaceuticals Post-IPO Equity 0
3/2014 Lumena Pharmaceuticals Series B 45M
6/2003 Phenomix Series A 11.6M
3/2007 Phenomix Series C 55M
5/2013 Kite Pharma Series A 20M
9/2001 7TM Pharma Series A 15M
10/2005 Radiant Medical Venture Round 36M
6/2003 CyThera Venture Round 2M
11/2006 Cara Therapeutics Series C 24M
12/2012 Evofem Biosciences Series C 20.6M
7/1999 Wavtrace Venture Round 24M
10/2004 Xelerated Venture Round 10M
6/2006 Aegerion Pharmaceuticals Series A 22.5M
4/2000 ProjectGuides.com Series B 6.3M
10/2004 7TM Pharma Series B 7.6M
4/2022 Free Market Health Series A 0
2/2014 Evofem Biosciences Series C 8M
11/2007 Aegerion Pharmaceuticals Series B 0
12/2000 PamGene Series A 6.2M
4/2022 Kelonia Therapeutics Series A 0
10/2010 Pathwork Diagnostics Series C 30M
7/2004 Vitra Bioscience Venture Round 5.5M
10/2003 Cotherix Series C 55M
6/2007 Kiadis Pharma Venture Round 0
11/2012 Applied Genetics Technologies Corporation Series B 0
7/2004 Phenomix Series A 2M
3/2015 aTyr Pharma Series E 76M
7/2010 Abionyx Pharma Series C 0
4/2013 Esperion Venture Round 33M
10/2019 Variant Bio Series A 24.7M
3/2008 Trevena Series A 24M
2/2004 NeurogesX Series C 35M
7/2018 Qihan Biotech Series A 7.8M
5/2007 Nanomix Series D 7.3M
8/2018 Everside Health Private Equity Round 165M
8/2004 AGY Therapeutics Series C 9M
4/2000 CornerHardware Series B 21M
11/2007 Excaliard Pharmaceuticals Series A 15.5M
12/2012 Larimar Therapeutics Series D 21M
8/2005 Abionyx Pharma Series A 30.5M
1/2009 Intradigm Corporation Series B 0
3/2021 DispatchHealth Series D 0
10/2004 MacroGenics Series B 30.5M
10/2010 aTyr Pharma Series C 23M
4/2003 Rigel Pharmaceuticals Post-IPO Equity 46M
6/2007 Ceregene Series C 0
8/2001 Eyetech Pharmaceuticals Series C 108.5M
11/2005 Portola Pharmaceuticals Series B 46M
3/2021 EGenesis Series C 0
4/2001 Genteric Series B 22M
7/2022 Everside Health Private Equity Round 164M
4/2004 Tacit Software Venture Round 7M
9/2009 aTyr Pharma Series C 12M
5/2009 Avid Radiopharmaceuticals Series D 0
7/2008 Immune Design Series A 18M
3/2007 Intarcia Therapeutics Venture Round 50M
10/2020 Transcarent Series A 40M
3/2002 Phenomix Series A 12M
3/2004 Insulet Series D 35.5M
7/2010 Immune Design Series B 32M
2/2006 Insulet Corporation Series E 0
5/2001 Ceyba Series B 93M
11/2004 Netli Venture Round 8M
6/2022 DEM BioPharma Series A 0
3/2014 ZS Pharma Series D 0
4/2005 Sanarus Medical Series D 23M
2/2007 Sanarus Medical Series E 15M
3/2010 TransMedics Series E 0
1/2008 Sonexa Therapeutics Series A 0
9/2008 Aegerion Pharmaceuticals Convertible Note 0
2/2000 Terawave Communications Series B 0
11/2007 Agami System Series C 50M
5/2006 Foldrx Pharmaceuticals Series B 43M
3/2021 Tyra Biosciences Series B 106M
1/2001 Nanomix Series A -
5/2012 Bioventus Venture Round 0
1/2022 Transcarent Series C 0
6/2021 Transcarent Series B 0
9/2000 TransMedics Series A 0
5/2000 eIndia Venture Round 0
1/2006 RedShift BioAnalytics Series A 12M
9/2004 Cellective Therapeutics Series A 27.5M
7/2010 Trevena Series B 35M
3/2011 Aerie Pharmaceuticals Series B 41.4M
2/2003 Coapt Systems Series C 12.2M
10/2001 Xelerated Series B 12M
4/2005 Phenomix Series B 20M
12/2013 Larimar Therapeutics Series E 45M
8/2006 Ablynx Series C 50M
7/2000 Cytos Series B 32M
7/2006 USGI Medical Series C 21M
9/2000 Intarcia Therapeutics Series C 38M
5/2001 Anesiva Series B 13M
4/2022 Be Biopharma Series B 0
8/2014 Allakos Series A 24.5M
3/2017 VertiFlex Equity 45.3M
4/1999 Intarcia Therapeutics Series B 12.1M
12/2004 Intarcia Therapeutics Series E 50M
11/2007 Carbylan Therapeutics Series B 20M
5/2001 Celetron International Private Equity Round 48M
6/2010 Foldrx Pharmaceuticals Venture Round 29M
9/2022 Novome Series B 0
3/2007 ChemGenex Pharmaceuticals Series A 16.4M
1/1999 The Medicines Company Venture Round -
6/2008 VertiFlex Series C 28.3M
3/2007 Calistoga Pharmaceuticals Series A 21M
6/2020 DispatchHealth Series C 135.8M
6/2004 ChemoCentryx Series B 33M
9/2017 DispatchHealth Venture Round 30.8M
1/2007 VertiFlex Series B 20M
12/2004 Myocor Series D 24M
1/2013 Carbylan Therapeutics Venture Round 6M
12/2007 Anesiva Post-IPO Equity 25M
5/2007 Arete Therapeutics Series A 35M
6/2010 Calistoga Pharmaceuticals Series C 40M
7/2003 Xelerated Holdings Venture Round 12.5M
6/2020 Lassen Therapeutics Series A 31M
10/2002 nCircle Network Security Series C 0
12/2003 USGI Medical Series B 12M
10/2005 OPAL Therapeutics Series A 6M
8/2014 St. George&s;s University Private Equity Round 750M
6/2001 Aevi Genomic Medicine Series A 7M
8/2007 Corcept Post-IPO Equity 10.1M
3/2006 Aegis Semiconductor Series D 8M
2/2011 Chimerix Series F 45M
3/2006 Aegis Lightwave Series D 8M
12/1997 Genteric Series A 9M
4/2005 Xelerated Series C 17M
7/2002 Anesiva Series C 50.4M
8/2004 Ceregene Series B 32M
9/2014 Allakos Series A 10M
1/2017 GenePeeks Series B 0
5/2009 Neothetics Series A -
1/2010 Virobay Debt Financing 300k
7/2014 Virobay Series B 8M
12/2006 SARcode Bioscience Venture Round 29M
7/2003 Xelerated Venture Round 12.5M
9/2022 Allakos Post-IPO Equity 0
1/1999 Arrow Therapeutics Seed Round 1.7M
3/2003 Tacit Software Series C 3.1M
2/2007 Proacta Series B 35M
6/2010 Virobay Venture Round 10M
1/2019 Vir Biotechnology Series B 327.6M
4/2007 TransMedics Series D 0
2/2004 Nanomix Series B 5M
12/2009 Coapt Systems Debt Financing 3.7M
10/2009 Corcept Post-IPO Equity 18M
3/2013 Achaogen Series D 18.9M
12/2004 CymaBay Therapeutics Series B 44M
7/2007 Agensys Series D 41.3M
3/2007 Coapt Systems Series E 22.6M
1/2002 NeurogesX Series B 22.9M
1/2020 Novome Biotechnologies Series A 0
8/2018 Everside Health Growth 165M
7/2022 Everside Health Venture Round 0
6/2022 DEM BioPharma Series A 0
4/2022 Kelonia Therapeutics Series A 0
4/2022 Free Market Health Series A 0
4/2022 Be Biopharma Series B 0
1/2022 Transcarent Series C 0
6/2021 ImmuneID Series A 0
6/2021 Transcarent Series B 0
3/2021 Tyra Biosciences Series B 0
3/2021 DispatchHealth Series D 0

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research
CoBee's Logo
Copyright © CoBee 2022. All Rights Reserved.